0 seconds of 45 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
00:45
00:45
 
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Sabre Resources (SBR) will begin a 3000-metre reverse circulation (RC) drilling program at its Nepean South farm-in project in Western Australia
  • The RC drilling will follow up on previous high-grade nickel results intersected in shallow rotary airblast drilling completed by Mincor Resources (MCR) between 2007 and 2012
  • Sabre’s upcoming RC drilling will test the basal ultramafic contact zone beneath the best RAB results identified to date
  • The company will also be undertaking a 2400-metre diamond drilling program at the Sherlock Bay nickel-copper-cobalt project to test for high-grade nickel sulphide targets
  • Shares in Sabre are steady on the market and are trading at 0.5 cents at 1:50 pm AEST

Sabre Resources (SBR) will begin a 3000-metre reverse circulation (RC) drilling program at its Nepean South farm-in project in Western Australia.

The RC drilling will follow up on previous high-grade nickel results intersected in shallow rotary airblast (RAB) drilling completed by Mincor Resources (MCR) between 2007 and 2012.

The RAB drilling returned intercepts of 12 metres at 1.29 per cent nickel from 15 metres including six metres at 1.84 per cent nickel and 0.02 per cent copper from 18 metres.

Sabre’s upcoming RC drilling will test the basal ultramafic contact zone beneath the best RAB results identified to date.

Simultaneously, a detailed drone magnetics survey will be flown along the entire length of Nepean South to define the ultramafics and fine-tune the nickel sulphide targets for further drilling.

The company will also undertake electromagnetic surveys over selected target areas to detect the potential for buried nickel sulphide zones.

Sabre submitted a program of work and expects it will be granted shortly.

An RC rig has arrived on site and subject to finalising terms and timing, drilling will begin as soon as possible.

Sabre will also be undertaking a 2400-metre diamond drilling program at the Sherlock Bay nickel-copper-cobalt project to test for high-grade nickel sulphide targets.

The start of the drilling program was delayed due to high rainfall, however, access and site preparation will be carried out this week with drilling to begin shortly after.

Sabre’s key objective of this drilling is to expand and upgrade the existing JORC resources which in turn will enable the company to update the Sherlock Bay scoping study.

The WA Government has approved co-funding of 50 per cent of the drilling costs and is capped at $220,000.

“Sabre has generated multiple high-grade nickel sulphide targets across its key projects at Sherlock Bay and now at the Nepean South Project. Both properties are within proven nickel sulphide-bearing corridors with massive sulphide potential targeted,” CEO Jon Dugdale said.

“The diamond drilling at Sherlock Bay and the RC drilling planned for Nepean South are testing below previously identified nickel mineralisation, so the chances of success are high.

“We see these programs as only the first step as we look to identify new high-grade nickel sulphide zones and build the company’s nickel sulphide resource base for future development.”

Shares in Sabre were steady on the market and were trading at 0.5 cents at 1:50 pm AEST.

SBR by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next